Conversation Point

Liver Cancer Diagnostics Market Size is Estimated to Exhibit $15.4 Billion By 2025: Grand View Research, Inc

 Breaking News
  • No posts were found

Liver Cancer Diagnostics Market Size is Estimated to Exhibit $15.4 Billion By 2025: Grand View Research, Inc

August 19
11:48 2019
Liver Cancer Diagnostics Market Size is Estimated to Exhibit $15.4 Billion By 2025: Grand View Research, Inc

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research, The global liver cancer diagnostic market size was valued at USD 8.25 billion in 2017 and is projected to expand at a healthy CAGR of 8.1% during the forecast period.

The global Liver Cancer Diagnostics Market size is expected to reach USD 15.4 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 8.1% over the estimated time period. Rise in disease incidence coupled with growing demand for novel diagnosis products are thrusting the growth of the market. Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer in adults. It is among the common causes of death in people with liver cirrhosis and the third-leading cause of cancer deaths across the globe. Poor survival rate and lack of therapies has made this disease a crucial health issue worldwide.

Government and some global health organizations are undertaking initiatives to raise awareness regarding liver cancer through various campaigns. These programs aim to create awareness about signs, symptoms, and complications associated with carcinomas. High costs associated with cancer treatments compared to other diseases have led to increasingly rigid treatment guidelines for expensive drugs and diagnostic tests across various markets. For instance, the Affordable Care Act, designed to improve quality of healthcare and reduce the cost associated with it. This act covers reimbursement for cancer diagnosis and treatment up to a certain extent. Governments in other countries are also taking efforts to overcome challenges, such as cost and access to cancer care.

Such efforts and insurance policies that cover cost of diagnosis and treatment of carcinomas are supporting market growth. Newer techniques developed for hepatocellular carcinoma render both liver transplant, as well as surgical resection, more effective and safer. Several etiological factors of HCC such as hepatitis infection and cirrhosis are modifiable and thus present a strong prospect to reduce disease mortality by preventive strategies. Key players and medical institutions are focusing on the development of advanced tests for HCC diagnosis. These factors along with high unmet needs are expected to propel the growth of liver cancer diagnostics market through the forecast period.

U.K. liver cancer diagnostic market size, by screening type, 2014 - 2025 (USD Million)


Request a Sample Copy of the Global Liver Cancer Diagnostics Market Research Report @
https://www.grandviewresearch.com/industry-analysis/liver-cancer-diagnostic-market/request/rs1

Further key findings from the study suggest:

  • Increasing awareness about liver cancer across the globe is expected to be the major factor driving the market growth
  • Laboratory tests emerged as the largest segment owing to increased demand for effective diagnostic tests for HCC
  • Oncofetal and Glucoprotein antigens accounted for the largest share in biomarkers segment
  • North America led the global liver cancer diagnostic market in 2017 and will maintain the dominance in future on account of rising awareness about early diagnosis and demand for novel diagnostic tests in the region
  • Illumina, Inc.; Qiagen; F. Hoffmann-La Roche Ltd.; Siemens Healthcare GmbH; and Thermo Fisher Scientific are some of the leading industry participants

U.S. liver cancer diagnostic market share, by screening type, 2017 (%)

Have Any Query? Ask Our [email protected] https://www.grandviewresearch.com/inquiry/5693/ibb

Grand View Research has segmented the global liver cancer diagnostics market on the basis of screening type and region:

Liver Cancer Diagnostics Screening Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Laboratory TestsImaging
    • Biomarkers
      • Oncofetal and Glycoprotein Antigens
      • Enzymes and Isoenzymes
      • Growth Factors and Receptors
      • Molecular Markers
      • Pathological Biomarkers
      • Blood Tests
  • Endoscopy
  • Biopsy
  • Others

Liver Cancer Diagnostics Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa 

Browse Related Category @

Elastography Imaging Market – https://www.grandviewresearch.com/industry-analysis/elastography-imaging-market

Clinical Chemistry Analyzers Market – https://www.grandviewresearch.com/industry-analysis/clinical-chemistry-analyzer-market

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/liver-cancer-diagnostic-market